Biomarkers That Predict Response to High-Dose Aldesleukin in Metastatic Kidney Cancer or Metastatic Melanoma
University of Nebraska
University of Nebraska
SWOG Cancer Research Network
University of Washington
Fred Hutchinson Cancer Center
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Yale University
Duke University
Mayo Clinic
National Cancer Institute (NCI)